Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Baucus Takes “Patient-Centered” Focus For Comparative Effectiveness In Bill

Executive Summary

The changes Sen. Max Baucus made in a reintroduced comparative effectiveness bill may be small compared to the 2008 version, but they suggest a different focus that might be a more welcome approach by the pharma industry

You may also be interested in...



Long-Time HELP Democrat Sen. Barbara Mikulski Plans To Retire By 2017

Maryland Sen. Barbara Mikulski (D), the body’s longest-serving female Senator, former Appropriations Committee Chair and advocate of quality and comparative effectiveness provisions in the Affordable Care Act, recently announced her plans not to seek re-election in 2016 and retire.

PCORI Board Lays CER Groundwork With Environmental Scans, “Tier 1” Grants

The Patient-Centered Outcomes Research Institute board of governors approved two actions that are expected to form the foundation of its future work: conducting environmental scans and developing the process for awarding “tier 1” grants.

PCORI Board Lays CER Groundwork With Environmental Scans, “Tier 1” Grants

The Patient-Centered Outcomes Research Institute board of governors approved two actions that are expected to form the foundation of its future work: conducting environmental scans and developing the process for awarding “tier 1” grants.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS051157

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel